Search results
Skye Bioscience to stop eye disease drug development after failing mid-stage study
Reuters via Yahoo News· 3 days agoIn the 56-subject study, the eye drop, SBI-100, failed to significantly lower eye pressure in patients with primary open-angle glaucoma when compared with the placebo, the company said. In this ...
Radiotherapy delivered by robots could improve treatment for common eye disease
Press Association News via AOL· 2 days agoThe savings made from a fall in the number of jabs were also larger than the cost of the...
A look at various eye diseases and the role of prescription sunglasses
The Times of Northwest Indiana· 6 days agoContributor content. Prescription sunglasses, especially those with polarized lenses, can be...
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
Investor's Business Daily· 3 days agoSkye stock plunged to its lowest-ever point Monday after the biotech company scrapped its failed eye...
There is no science behind eye exercises to improve sight
Popular Science via Yahoo News· 6 days agoThis article was originally featured on The Conversation. You may have seen advertisements claiming...
Skye Bioscience to stop eye disease drug development after failing mid-stage study
WSAU Wausau· 3 days ago(Reuters) -Skye Bioscience said on Monday it would discontinue development of its experimental eye disease treatment after the drug failed to meet the main ...
MacTel2 Treatment: With Easier Ways to Adapt to Vision Loss
Verywell Health via Yahoo News· 2 days agoThis article describes the treatments for MacTel2 and lifestyle recommendations for living with this...
How to identify ultra-processed foods (UPFs) – and the surprising ones hiding in your cupboard
The Telegraph via Yahoo News· 21 hours agoIt’s impossible to avoid warnings about the dangers of eating too much ultra-processed food (UPF),...
IRIDEX (NASDAQ:IRIX) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 8 hours agoStock analysts at StockNews.com assumed coverage on shares of IRIDEX (NASDAQ:IRIX – Get Free Report) in a report released on Thursday. The brokerage set a “hold” rating on the medical equipment ...
Skye Bioscience to stop eye disease drug development after failing mid-stage study
Reuters· 3 days ago, opens new tab said on Monday it would discontinue development of its experimental eye disease treatment after the drug failed to meet the main goal of ...